Abstract
We have been investigating experimentally the factors which initiate and perpetuate ocular neovascularization (NV). Our studies can be divided into four categories: (1) production of a primate experimental model of ocular NV, (2) morphological studies, (3) tissue culture studies, and (4) biochemical studies. We have been successful in producing a reliable primate model of ocular NV following retinal vein occlusion (RVO). The morphological and fluorescein angiographic studies have established that the new vessels seen in the animal model represent true NV and not simple dilatation of the pre-existing vessels. The tissue culture studies have shown the presence of vasoproliferative activity in the intraocular fluids in eyes with ocular NV in our animal model. The various biochemical studies conducted so far have provided preliminary results on various aspects, including the protein electrophoretic pattern and lysosomal enzymes in the intraocular fluids from eyes with and without ocular NV and effects of anoxia and of corticosteroids. The results of our various studies are very briefly reviewed and the importance of angiogenesis is discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ben Ezra D: Neovasculogenic ability of prostaglandins, growth factors and chemoattractants. Am J Ophthalmol 86: 455–461, 1978.
Bito LZ: Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. Exp Eye Res 38: 181–194, 1984.
Bito LZ, Draga A, Blanco J, Camras CB: Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes. Invest Ophthalmol Vis Sci 24: 312–319, 1983.
Camras CB, Bito LZ: Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2a. Curr Eye Res 1: 205–209, 1981.
Camras CB, Bito LZ, Eakins KE: Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest Ophthalmol Vis Sci 16: 1125–1134, 1977.
Crum R, Szabo S, Folkman J: A new class of steroids inhibit angiogenesis in the presence of heparin or a heparin derivative. Science 230: 1375–1378, 1985.
D'Amore PA, Klagsbrun M: Endothelial cell mitogens derived from retina and hypothalmus: Biochemical and biological similarities. J Cell Biol 99: 1545–1549, 1984.
Elstow SF, Schor AM, Weiss JB: Bovine retinal angiogenesis factor is a small molecule (molecular mass less than 600). Invest Ophthalmol Vis Sci 26: 74–79, 1985.
Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R: Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82: 6507–6511, 1985.
Fernandez LA, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 105: 141–145, 1985.
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallée BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24: 5480–5486, 1985.
Folkman J: Regulation of angiogenesis: A new function of heparin. Biochem Pharmacol 34: 905–909, 1985.
Folkman J, Merler E, Abernathy C, Williams G: Isolation of a tumour factor responsible for angiogenesis. J Exp Med 133: 275–288, 1971.
Form DM, Auerbach R: PGE2 and angiogenesis. Proc Soc Exp Biol Med 172: 214–218, 1983.
Francois J: The importance of the mucopolysaccharides in intra-ocular pressure regulation. Invest Ophthalmol 14: 173–176, 1975.
Goldsmith HS, Griffith AL, Kupferman A, Catsimpoolas N: Lipid angiogenic factor from omentum. J Am Med Assoc 252: 2034–2036, 1984.
Grierson I, Lee WR, Abraham S: A light microscopic study of the effects of testicular hyaluronidase on the outflow system of a baboon (Papio cynocephalus). Invest Ophthalmol Vis Sci 18: 356–360, 1979.
Gu X-Q, Fry GL, Lata GF, Packer AJ, Servais EG, Hoak JC, Hayreh SS: Ocular neovascularization - Tissue culture studies. Arch Ophthalmol 103: 111–117, 1985.
Hayreh SS: Ocular neovascularization. Int Ophthalmol 2: 27–32, 1980.
Hayreh SS, March W, Phelps CD: Ocular hypotony after retinal vascular occlusion. Trans Ophthalmol Soc U.K. 97: 757–767, 1977.
Hayreh SS, March W, Phelps CD: Ocular hypotony following retinal vein occlusion. Arch Ophthalmol 96: 827–833, 1978.
Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF: Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90: 488–506, 1983.
Imre G: The role of increased lactic acid concentration in neovascularization. Acta Morphol Hung 32: 97–103, 1984.
Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ: Oxygen tension regulates the expression of angiogenesis factor by macrophage. Science 221: 1283–1285, 1983.
Kulkarni PS, Srinivason BD: Prostaglandins E3 and D3 lower intraocular pressure. Invest Ophthalmol Vis Sci 26: 1178–1182, 1985.
Kumar P, Erroi A, Sattar A, Kumar S: Weibel-Palade bodies as a marker for neovascularization induced by tumor and rheumatoid angiogenesis factors. Cancer Res 45: 4339–4348, 1985.
Mahadevan S, Dillard CT, Tappel AL: Degradation of polysaccharides, monosaccharides, and glycoproteins by lysosomal glycosidases. Arch Biochem Biophys 129: 525–533, 1968.
Makris A, Ryan KJ, Yasumizu T, Hill CL, Zetter BR: The non-luteal porcine ovary as a source of angiogenic activity. Endocrinology 115: 1672–1677, 1984.
Morgan KM, Bruner WE, Lata GF, Hayreh SS: Beta-N-Acetyl-Glucosaminidase: Possible role in ocular neovascularization. Int Ophthalmol 9: 129–137.
Moscatelli DA, Rifkin DB & Jaffe EA: Induction of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations. Exp Cell Res 156: 379–390, 1985.
Nork TM, Tso MOM, Hayreh SS, Duval J: Cellular mechanisms of iris neovascularization secondary to retinal vein occlusion. Invest Ophthalmol Vis Sci 26(ARVO Suppl): 169, 1985.
Packer AJ, Gu X-Q, Servais EG, Hayreh SS: Primate model of neovascular glaucoma. Int Ophthalmol 9: 121–127.
Saxe AW: Angiogenesis of human parathyroid tissue. Surgery 96: 1138–1143, 1984.
Shahabuddin S, Kuman S, West D, Arnold F: A study of angiogenesis factors from five different sources using a radio-immunoassay. Int J Cancer 35: 87–91, 1985.
Stern FA & Bito LZ: Comparison of the hypotensive and other ocular effects of prostaglandins E2 and F2a on cat and rhesus monkey eyes. Invest Ophthalmol Vis Sci 22: 588–598, 1982.
Teuscher E, Weidlick V: Adenosine nucleotides, adenosine and adenine as angiogenesis factors. Biomed Biochem Acta 44: 493–495, 1985.
Thompson WD, Campbell R, Evane T: Fibrin degradation and angiogenic response in the chick chorioallantoic membrane. J Pathol 145: 27–37, 1985.
Virdi PS, Hayreh SS: Ocular neovascularization with retinal vascular occlusion-I. Association with experimental retinal vein occlusion. Arch Ophthalmol 100: 331–341, 1982.
West DC, Hampson IN, Arnold F, Kumar S: Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324–1326, 1985.
Ziche M, Ruggiero M, Pasquali F & Chiarugi VP: Effects of cortisone with and without heparin on angiogenesis induced by PGE1 and by S180 cells, and on growth of murine transplantable tumors. Int J Cancer 35: 549–552, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayreh, S.S., Lata, G.F. Ocular neovascularization. Int Ophthalmol 9, 109–120 (1986). https://doi.org/10.1007/BF00159839
Issue Date:
DOI: https://doi.org/10.1007/BF00159839